Anna Törner: Kalashnikovs in a new guise

Thanks to resisting European regulatory authorities, Europe has been spared the opioid epidemic. In the 1960s, the situation was the opposite as the American ph...

Växande bransch i Danmark – "Ett nytt life science-företag i veckan"

Life science-sektorn i östra Danmark fortsätter att växa, både i antal anställda och antal företag. Ett uppseglande problem är bristen på arbetskraft, enligt en ny rapport.

Petter Hartman: Lust som drivkraft för livslångt lärande

”För att det livslånga lärandet ska bli mer än vackra ord krävs att rätt förutsättningar finns", skriver Petter Hartman i en krönika.

Welcome to wonderful Copenhagen

Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...

Kancera går vidare till klinisk Fas I

Läkemedelskandidaten KAND567 har fått godkänd för start av klinisk prövning.

Addvise köper MRC Systems

Planerar ett köp för upp till åtta miljoner dollar.

Biovitrum sells UK part

Biovitrum will soon spin-out a British subsidary

Fat cells' reaction differs with body weight

The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...

IVI’s Director General on establishing in Sweden: Will need up to 40 employees

The International Vaccine Institute, IVI, hopes to have its first staff on-site in Stockholm within a couple of months, says the institute’s Director General Je...

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

Innovationshubben i Matfors har haft sin första kund – "Full fart nu"

Gammal utrustning rivs ut – nya toppmoderna labb för processutveckling och analys kommer på plats. På Northx Biologics i Matfors pågår arbetet för fullt med att...

A green nursery for biotech rooted in the Scanian soil

Red Glead has established itself as one of Lund’s largest companies in pharmaceutical development. Life Science Sweden went to Skåne and met two of the founders...

An industry emerging from crisis

"Scanlab is normally indicative of the status of investment incentives in the laboratory industry "

"Det ligger i allas intresse att samarbeta"

Virononas vd Mohammed Homman kommenterar SwedenBios förslag om att inrätta program för explorativ samverkansforskning inom life science.

Hallå där Dag Larsson ...

Dag Larsson, Senior Policy Manager på Lif, ska tala på Life Science Swedens event Pharma Outsourcing den 10 december.

“I am driven by the desire to develop a product that can be sold worldwide”

Ranked number one in the world by the WHO in diarrhoea research and soon in phase III studies for its vaccine candidate – Scandinavian Biopharma is rushing forw...

Hur Gör Man För Att Handla Med Aktier?

En aktiemarkand fungerar i naturen på samma sätt precis som vid vilken handel som helst mellan två givna parter.

Ambassador program makes MVA big in Japan

The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...

How to get the most out of the fair

Näringslivet backar KI:s forskning om immunterapi

Nu har tio svenska och internationella företag gemensamt gått ihop med forskare vid Karolinska institutet, KI, för att utveckla cancervården. Det handlar om utv...

The stomach medication that became the biggest blockbuster of the 1990s

The omeprazole molecule was synthesised as early as 1979, but it took many years before the then Astra had an approved pharmaceutical. Once this happened, a tab...

Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation

A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure t...

EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.

WWF ska kartlägga Astrazenecas vattenförvaltning

Tillsammans med Världsnaturfonden, WWF, ska läkemedelsbolaget analysera vilken inverkan företagets verksamhet har på vatten.